Phase
Condition
Stroke
Occlusions
Thrombosis
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Ischemic lesions in the territory of middle cerebral artery subcortical orsubcortical/cortical confirmed neuroimaging
Inclusion must be in the sub-acute phase defined as within 2-4 weeks after stroke
Persistent hemiparesis, indicated by a score of 1-3 on the motor arm item of the NIHStroke Scale (NIHSS) (Brott et al. 1989) but wrist and finger movement is not required
No UE injury or conditions that limited use prior to the stroke.
The patient is >18 years old.
The patient has subscribed the informed consent
Exclusion
Exclusion Criteria:
History of epilepsy, brain tumor, major head trauma, learning disorder, severecognitive impairment, drug or alcohol abuse, major psychiatric illness
Use of medications that may lower seizure threshold (e.g., metronidazole,fluoroquinolones)
Severe pain in the affected upper limb (>=8 on the shoulder item of the "joint painduring passive motion" of the Fugl-Meyer Assessment Upper Extremity)
Further stroke or other significant medical complication during the study
Evidence of severe leucoencephalopathy (grade IV according to the Fazeka's scale)
Important aphasia that would impair the understanding and performance of theassessment scales
Study Design
Connect with a study center
Universitätsspital Bern, Inselspital, Neuropsychologische Rehabilitation
Bern, 3010
SwitzerlandSite Not Available
Clinica Hildebrand, Centro di riabilitazione Brissago
Brissago, 6614
SwitzerlandActive - Recruiting
HELIOS Klinik Zihlschlacht AG, Neurologisches Rehabilitationszentrum
Zihlschlacht, 8588
SwitzerlandTerminated
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.